Related Experiment Video
Updated: Mar 15, 2026
10:50
Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
Published on: July 16, 2018
17.1K
A nanobiosensor for the detection of arginase activity
Aruni P Malalasekera1, Hongwang Wang1, Thilani N Samarakoon1
1Department of Chemistry, Kansas State University, Manhattan, KS, USA.
Nanomedicine : Nanotechnology, Biology, and Medicine
|August 26, 2016
Summary
A novel nanobiosensor detects arginase with picomolar sensitivity. This tool reveals enhanced arginase activity in aggressive breast cancer models, offering new diagnostic potential.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Enzyme Assays
Background:
- Arginase enzymes play a role in inflammatory responses associated with cancer and infections.
- Accurate detection of arginase activity is crucial for understanding disease progression.
Purpose of the Study:
- To design and synthesize a highly sensitive nanobiosensor for arginase detection.
- To evaluate the nanobiosensor's specificity and performance in a preclinical cancer model.
Main Methods:
- Synthesis of a nanobiosensor using dopamine-coated iron/iron oxide nanoparticles, sulfonated cyanine 7.0, and a peptide sequence.
- Utilizing fluorescence changes to quantify arginase activity.
- Testing the nanobiosensor in a 4T1 breast cancer mouse model.
Main Results:
- The nanobiosensor achieved a picomolar limit of detection for arginase.
- Demonstrated specificity, with no significant response to NO-reductase.
- Observed significantly enhanced arginase activity in tumor regions of the mouse model.
Conclusions:
- The developed nanobiosensor is a sensitive and specific tool for arginase detection.
- Arginase activity is elevated in aggressive breast cancer, particularly within tumor sites.
- This nanobiosensor holds promise for cancer diagnostics and monitoring.
